These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12806171)

  • 1. High dose cyclophosphamide treatment for autoimmune disorders.
    Brodsky RA
    ScientificWorldJournal; 2002 Jun; 2():1808-15. PubMed ID: 12806171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose cyclophosphamide for aplastic anemia and autoimmunity.
    Brodsky RA
    Curr Opin Oncol; 2002 Mar; 14(2):143-6. PubMed ID: 11880702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
    DeZern AE; Petri M; Drachman DB; Kerr D; Hammond ER; Kowalski J; Tsai HL; Loeb DM; Anhalt G; Wigley F; Jones RJ; Brodsky RA
    Medicine (Baltimore); 2011 Mar; 90(2):89-98. PubMed ID: 21358440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.
    Brodsky RA; Sensenbrenner LL; Jones RJ
    Blood; 1996 Jan; 87(2):491-4. PubMed ID: 8555470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
    Brodsky RA; Sensenbrenner LL; Smith BD; Dorr D; Seaman PJ; Lee SM; Karp JE; Brodsky I; Jones RJ
    Ann Intern Med; 2001 Oct; 135(7):477-83. PubMed ID: 11578150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cyclophosphamide for autoimmunity and alloimmunity.
    Brodsky RA
    Immunol Res; 2010 Jul; 47(1-3):179-84. PubMed ID: 20087683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
    Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
    Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
    Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
    Brodsky RA; Jones RJ
    Autoimmunity; 2008 Dec; 41(8):596-600. PubMed ID: 18958751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
    Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?
    Takizawa H; Ito K
    Intern Med; 1997 Jul; 36(7):448-9. PubMed ID: 9240490
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
    Jaime-Pérez JC; González-Llano O; Gómez-Almaguer D
    Am J Hematol; 2001 Jan; 66(1):71. PubMed ID: 11426504
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
    Nousari HC; Brodsky RA; Jones RJ; Grever MR; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):750-4. PubMed ID: 10321604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission of refractory anemia following a single high dose of cyclophosphamide.
    Ferrara F; Copia C; Annunziata M; di Noto R; Russo C; Palmieri S; Spasiano A; del Vecchio L
    Ann Hematol; 1999 Feb; 78(2):87-8. PubMed ID: 10089024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
    Ambulkar I; Parikh PM; Saikia T
    J Assoc Physicians India; 2003 Jul; 51():715-6. PubMed ID: 14621044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
    Brodsky RA; Petri M; Smith BD; Seifter EJ; Spivak JL; Styler M; Dang CV; Brodsky I; Jones RJ
    Ann Intern Med; 1998 Dec; 129(12):1031-5. PubMed ID: 9867758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide in dermatology.
    Kim J; Chan JJ
    Australas J Dermatol; 2017 Feb; 58(1):5-17. PubMed ID: 26806212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.